Complete Guide to ORS™ Pricing and ROI

ORS™ (Operational Regulation Systems), built by Matthew F. Stevens, is priced as an engagement-based investment rather than a fixed software license, meaning cost depends on organization size, site count, and engagement scope rather than a flat per-seat rate. This guide covers how that pricing structure works, how to build a defensible ROI model around it, how pricing scales for multi-site organizations, and how to present the full cost case internally.

Why ORS™ Isn’t Priced Like Software

A per-seat software license model assumes a roughly linear relationship between headcount and value delivered — twice as many users, twice the license cost. ORS™’s engagement-based structure reflects a different reality: much of the value comes from operational-level changes — scheduling design, escalation protocols, queue management — that apply organization-wide regardless of exact headcount, alongside individual and supervisor-level components that do scale with team size. This is why ORS™ pricing conversations start with a discovery process rather than a published rate card: the actual engagement scope depends on organizational specifics a fixed price list can’t capture accurately.

The Baseline Cost Anchor: The $130,000 Figure

A useful anchor point published as part of ORS™’s own cost material is a baseline estimate of roughly $130,000 in annual attrition-related cost for a 200-agent floor. This figure isn’t meant to represent the cost of ORS™ itself — it represents the estimated cost of the problem ORS™ is meant to address, providing a reference point against which engagement cost and expected return can both be evaluated.

Rebuilding the Figure With Your Own Numbers

Rather than treating $130,000 as a universal number, an organization should rebuild this calculation using its own actual headcount, actual attrition rate, and actual fully loaded replacement cost per departure — recruiting spend, onboarding time, productivity ramp-up, and the coverage gap itself. A 400-agent floor with a higher-than-average attrition rate could have a baseline cost multiple times the reference figure; a smaller, lower-attrition floor could have considerably less.

How Pricing Scales for Multi-Site Organizations

Multi-site and multi-account organizations should expect ORS™ pricing to scale with the number of sites and their specific conditions, though not necessarily on a simple linear per-site basis. Some elements of an engagement — the initial discovery and diagnostic framework, certain organizational-level training components — can be developed once and adapted across sites more efficiently than building each site’s engagement entirely from scratch, which can produce genuine economies of scale for larger multi-site rollouts.

Sequencing Multi-Site Investment

Organizations with multiple sites don’t need to commit to full simultaneous rollout to get meaningful pricing clarity — starting with the highest-need site as an initial engagement, then using that site’s real cost and results data to model the remaining sites’ pricing and expected return, tends to produce both a more accurate multi-site cost model and a lower-risk initial commitment.

Building the ROI Model

A credible ROI model connects three numbers: the baseline cost of the current problem, the total cost of the ORS™ engagement, and a conservatively modeled percentage reduction in the baseline cost as a result of the engagement. The gap between the baseline cost reduction and the engagement cost is the projected net return; dividing the engagement cost by the monthly rate of savings gives the payback period.

Why the Reduction Assumption Should Be Conservative and Explicit

An ROI model built on an aggressive, unstated reduction assumption is fragile under scrutiny. Stating the assumption explicitly — for example, modeling a conservative percentage reduction in attrition-related cost, clearly labeled as an assumption rather than a guarantee — and presenting both a conservative and an optimistic case gives a finance-literate audience something they can evaluate and challenge on its own terms, rather than a single unverifiable number.

Including Escalation and Quality Cost, Not Just Attrition

A fuller ROI model extends beyond attrition-related cost to include the cost of escalation-driven quality failures and productivity loss from performance variability — both usually already tracked in some form but rarely connected explicitly to a regulation-focused root cause, and both can materially strengthen the overall cost case when included.

Timeline: When the Return Actually Shows Up

ORS™’s published timeline points to measurable shifts within the first 30 days across agent, supervisor, and organizational levels, with a fuller evaluation typically happening around a 90-day checkpoint. A cost-justification model should build this timeline directly into the payback-period calculation, rather than assuming savings begin accruing from day one of the engagement, since the ramp from initial implementation to full measurable effect isn’t instantaneous.

Modeling a Ramp Curve Rather Than a Step Change

A more accurate model treats the transition from baseline cost to reduced cost as a gradual ramp across the first 90 days rather than an instantaneous step change on day one — modeling, for instance, partial improvement by day 30 and fuller improvement by day 90 produces a more conservative and more defensible payback-period estimate than assuming full benefit begins immediately at signing.

What’s Included vs. What Costs Extra

Engagement scope and what’s included in a given price point varies by organization, but the discovery process should surface a clear answer to what’s covered under the initial engagement fee versus what would represent an additional cost — ongoing support beyond the initial period, expansion to additional sites, or deeper internal-capability-building components, for instance. Getting clarity on this distinction before signing avoids a cost-justification model becoming inaccurate midway through the engagement.

Presenting the Full Cost Case

The strongest cost presentations lead with the baseline cost of the current, unaddressed problem before introducing the engagement cost and projected return — establishing that the status quo is itself expensive makes the proposed investment read as a comparison between two real costs, rather than an unprompted new expense being introduced in isolation. A presentation that opens with engagement cost before establishing why the current situation is expensive tends to trigger sticker-shock reactions that a properly sequenced presentation avoids.

Common Cost-Justification Mistakes

The most common mistake is presenting a single point-estimate ROI figure without showing the underlying assumptions, which invites a skeptical reviewer to simply reject the number rather than engage with the reasoning behind it. A second common mistake is comparing ORS™’s cost only against “doing nothing,” rather than against the realistic cost of the status quo continuing to produce the same attrition and escalation levels indefinitely — the true comparison isn’t zero cost versus engagement cost, it’s ongoing unaddressed cost versus engagement cost plus reduced ongoing cost.

Why Comparing Against Competing Vendors Can Backfire

Building a cost case primarily around being cheaper than a specific named competitor tends to read as defensive positioning rather than a confident, standalone case — a stronger approach anchors the entire justification to the organization’s own baseline cost and expected return, treating vendor comparison as a secondary consideration rather than the primary argument.

Revisiting Cost Assumptions After the Pilot

Once an initial pilot or engagement is underway, the original cost model should be revisited with real data at the agreed checkpoint rather than left as a static projection. If actual attrition or escalation reduction differs meaningfully from the model’s assumptions, that gap is itself useful information — it either reveals a data-quality issue in the original baseline, a slower-than-expected rollout, or a genuine signal that the engagement scope needs adjustment before committing to a larger, multi-site rollout.

Frequently Asked Questions

Does ORS™ pricing differ by industry?

Pricing is driven primarily by organization size, site count, and engagement scope rather than industry classification itself, though industry-specific factors like regulatory complexity in healthcare can affect the scope of the discovery and implementation process.

Is there a minimum engagement size or cost?

ORS™ doesn’t require a minimum company size to implement, but very small engagements should be scoped carefully to ensure the pilot is large enough to generate statistically meaningful before/after data.

How does ORS™ pricing compare to a typical corporate wellness program?

Direct comparison is difficult since the two address different problems, but wellness programs are typically priced per-employee as an ongoing subscription cost, while ORS™ is priced as a scoped engagement tied to a specific expected operational outcome and defined checkpoint.